
Abbvie Inc (ABBV) Stock: A Closer Look at the Market Potential
The price-to-earnings ratio for Abbvie Inc (NYSE: ABBV) is above average at 79.61x, Company’s 36-month beta value is 0.53.Analysts have differing opinions on the stock,
The price-to-earnings ratio for Abbvie Inc (NYSE: ABBV) is above average at 79.61x, Company’s 36-month beta value is 0.53.Analysts have differing opinions on the stock,
Abbvie Inc (NYSE: ABBV)’s stock price has soared by 3.15 in relation to previous closing price of 180.37. Nevertheless, the company has seen a gain
The price-to-earnings ratio for Abbvie Inc (NYSE: ABBV) is above average at 72.33x, Company’s 36-month beta value is 0.63.Analysts have differing opinions on the stock,
The price-to-earnings ratio for Abbvie Inc (NYSE: ABBV) is 73.19x, which is above its average ratio. Moreover, the 36-month beta value for ABBV is 0.62.
The stock of Abbvie Inc (ABBV) has seen a -8.93% decrease in the past week, with a -11.29% drop in the past month, and a
In the past week, ABBV stock has gone up by 0.55%, with a monthly gain of 0.61% and a quarterly surge of 17.36%. The volatility
The stock of Abbvie Inc (ABBV) has seen a -0.83% decrease in the past week, with a 4.54% gain in the past month, and a
The stock of Abbvie Inc (ABBV) has seen a -0.83% decrease in the past week, with a 4.54% gain in the past month, and a
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.